Apr 22 |
EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent
|
Apr 12 |
Adial Pharmaceuticals files to sell 2.37M common shares for holders
|
Apr 12 |
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
|
Apr 11 |
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today
|
Apr 10 |
S&P 500 Down 1%; Delta Air Lines Posts Upbeat Earnings
|
Apr 10 |
Adial stock rallies 81% on data for alcohol abuse drug
|
Apr 10 |
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
|
Apr 2 |
Adial Pharmaceuticals reports FY results
|
Apr 2 |
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
|
Mar 11 |
Peering Into Adial Pharmaceuticals's Recent Short Interest
|